Pharmaceutical Excipients for Non-injection - Global and China Top Players Market Share and Ranking 2023
According to the research report, the global market for Pharmaceutical Excipients for Non-injection should grow from US$ 4682 million in 2022 to US$ 8997.9 million by 2029, with a CAGR of 9.7% for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Pharmaceutical Excipients for Non-injection market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Pharmaceutical Excipients for Non-injection market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Tablets grew percent to account for percent of the total market sales, and Capsules grew percent.
Pharmaceutical excipients are the inactive substances that are added to a drug formulation to improve its stability, bioavailability, palatability, and other properties. They are generally regarded as safe (GRAS) by regulatory agencies and are used in various dosage forms, such as tablets, capsules, oral liquids, topical creams, and inhalers.
This report studies and analyses global Pharmaceutical Excipients for Non-injection status and future trends, helps the client to determine the Pharmaceutical Excipients for Non-injection market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Pharmaceutical Excipients for Non-injection, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Report Highlights
(1) Global Pharmaceutical Excipients for Non-injection market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Pharmaceutical Excipients for Non-injection sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Pharmaceutical Excipients for Non-injection sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Pharmaceutical Excipients for Non-injection key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Pharmaceutical Excipients for Non-injection key producing regions, capacity, production, and year over year growth
(6) Pharmaceutical Excipients for Non-injection industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Dow
Nippon Fine Chemical
Nanjing Well Pharmaceutical
Jiangsu Maxim Biological
NOF
Croda
Jiangsu Poly Pharmaceutical
Er Kang Pharmaceutical
Guangzhou Hanfang Pharmaceutical
Pfanstiehl
Xi'an Libang Pharmaceutical
Zhejiang Tianyushan Medicinal Oil
Market segment by Type, covers
Binders
Disintegrants
Lubricants
Fillers
Others
Market segment by Application, can be divided into
Tablets
Capsules
Oral Liquids
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Key Findings from The Report:
Chapter 1: to describe Pharmaceutical Excipients for Non-injection product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Pharmaceutical Excipients for Non-injection market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Pharmaceutical Excipients for Non-injection market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Pharmaceutical Excipients for Non-injection, percent & CAGR, 2018-2029
Chapter 5: Pharmaceutical Excipients for Non-injection industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Pharmaceutical Excipients for Non-injection Definition
1.2 Global Pharmaceutical Excipients for Non-injection Market Size and Forecast
1.2.1 By Consumption Value, Global Pharmaceutical Excipients for Non-injection Market Size，2018-2029
1.2.2 By Sales Quantity, Global Pharmaceutical Excipients for Non-injection Market Size，2018-2029
1.2.3 Global Pharmaceutical Excipients for Non-injection Average Selling Price (ASP)，2018-2029
1.3 China Pharmaceutical Excipients for Non-injection Market Size and Forecast
1.3.1 By Consumption Value, China Pharmaceutical Excipients for Non-injection Market Size，2018-2029
1.3.2 By Sales Quantity, China Pharmaceutical Excipients for Non-injection Market Size，2018-2029
1.3.3 China Pharmaceutical Excipients for Non-injection Average Selling Price (ASP)， 2018-2029
1.4 Share of China Pharmaceutical Excipients for Non-injection Market with Respect to the Global Market
1.4.1 By Consumption Value, China Pharmaceutical Excipients for Non-injection Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Pharmaceutical Excipients for Non-injection Market Share in Global, 2018-2029
1.4.3 Pharmaceutical Excipients for Non-injection Market Size: China VS Global, 2018-2029
1.5 Pharmaceutical Excipients for Non-injection Market Dynamics
1.5.1 Pharmaceutical Excipients for Non-injection Market Drivers
1.5.2 Pharmaceutical Excipients for Non-injection Market Restraints
1.5.3 Pharmaceutical Excipients for Non-injection Industry Trends
1.5.4 Pharmaceutical Excipients for Non-injection Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Pharmaceutical Excipients for Non-injection, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Pharmaceutical Excipients for Non-injection, Global Market Share by Company, 2018-2023
2.3 Pharmaceutical Excipients for Non-injection Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Pharmaceutical Excipients for Non-injection Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Pharmaceutical Excipients for Non-injection Concentration Ratio
2.6 Global Pharmaceutical Excipients for Non-injection Mergers & Acquisitions, Expansion Plans
2.7 Global Pharmaceutical Excipients for Non-injection Manufacturers Product Type
2.8 Head Office and Pharmaceutical Excipients for Non-injection Production Site of Key Manufacturer
2.9 Pharmaceutical Excipients for Non-injection Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Pharmaceutical Excipients for Non-injection, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Pharmaceutical Excipients for Non-injection, China Market Share by Company, 2018-2023
3.3 China Pharmaceutical Excipients for Non-injection Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Pharmaceutical Excipients for Non-injection Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Pharmaceutical Excipients for Non-injection Capacity by Region
4.3 Global Pharmaceutical Excipients for Non-injection Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Pharmaceutical Excipients for Non-injection Production by Region, 2018-2029
4.5 Global Pharmaceutical Excipients for Non-injection Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Pharmaceutical Excipients for Non-injection Industry Chain
5.2 Pharmaceutical Excipients for Non-injection Upstream Analysis
5.2.1 Pharmaceutical Excipients for Non-injection Core Raw Materials
5.2.2 Main Manufacturers of Pharmaceutical Excipients for Non-injection Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Pharmaceutical Excipients for Non-injection Production Mode
5.6 Pharmaceutical Excipients for Non-injection Procurement Model
5.7 Pharmaceutical Excipients for Non-injection Industry Sales Model and Sales Channels
5.7.1 Pharmaceutical Excipients for Non-injection Sales Model
5.7.2 Pharmaceutical Excipients for Non-injection Typical Distributors
6 Sights by Type
6.1 Pharmaceutical Excipients for Non-injection Classification
6.1.1 Binders
6.1.2 Disintegrants
6.1.3 Lubricants
6.1.4 Fillers
6.1.5 Others
6.2 By Type, Global Pharmaceutical Excipients for Non-injection Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Pharmaceutical Excipients for Non-injection Consumption Value, 2018-2029
6.4 By Type, Global Pharmaceutical Excipients for Non-injection Sales Quantity, 2018-2029
6.5 By Type, Global Pharmaceutical Excipients for Non-injection Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Pharmaceutical Excipients for Non-injection Segment by Application
7.1.1 Tablets
7.1.2 Capsules
7.1.3 Oral Liquids
7.1.4 Others
7.2 By Application, Global Pharmaceutical Excipients for Non-injection Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Pharmaceutical Excipients for Non-injection Consumption Value, 2018-2029
7.4 By Application, Global Pharmaceutical Excipients for Non-injection Sales Quantity, 2018-2029
7.5 By Application, Global Pharmaceutical Excipients for Non-injection Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Pharmaceutical Excipients for Non-injection Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Pharmaceutical Excipients for Non-injection Consumption Value, 2018-2029
8.3 By Region, Global Pharmaceutical Excipients for Non-injection Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Pharmaceutical Excipients for Non-injection & Forecasts, 2018-2029
8.4.2 By Country, North America Pharmaceutical Excipients for Non-injection Market Size Market Share
8.5 Europe
8.5.1 Europe Pharmaceutical Excipients for Non-injection Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Pharmaceutical Excipients for Non-injection Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Pharmaceutical Excipients for Non-injection Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Pharmaceutical Excipients for Non-injection Market Size Market Share
8.7 South America
8.7.1 South America Pharmaceutical Excipients for Non-injection Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Pharmaceutical Excipients for Non-injection Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Pharmaceutical Excipients for Non-injection Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Pharmaceutical Excipients for Non-injection Consumption Value, 2018-2029
9.3 By Country, Global Pharmaceutical Excipients for Non-injection Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Pharmaceutical Excipients for Non-injection Market Size, 2018-2029
9.4.2 By Type, U.S. Pharmaceutical Excipients for Non-injection Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Pharmaceutical Excipients for Non-injection Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Pharmaceutical Excipients for Non-injection Market Size, 2018-2029
9.5.2 By Type, Europe Pharmaceutical Excipients for Non-injection Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Pharmaceutical Excipients for Non-injection Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Pharmaceutical Excipients for Non-injection Market Size, 2018-2029
9.6.2 By Type, China Pharmaceutical Excipients for Non-injection Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Pharmaceutical Excipients for Non-injection Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Pharmaceutical Excipients for Non-injection Market Size, 2018-2029
9.7.2 By Type, Japan Pharmaceutical Excipients for Non-injection Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Pharmaceutical Excipients for Non-injection Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Pharmaceutical Excipients for Non-injection Market Size, 2018-2029
9.8.2 By Type, South Korea Pharmaceutical Excipients for Non-injection Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Pharmaceutical Excipients for Non-injection Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Pharmaceutical Excipients for Non-injection Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Pharmaceutical Excipients for Non-injection Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Pharmaceutical Excipients for Non-injection Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Pharmaceutical Excipients for Non-injection Market Size, 2018-2029
9.10.2 By Type, India Pharmaceutical Excipients for Non-injection Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Pharmaceutical Excipients for Non-injection Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Pharmaceutical Excipients for Non-injection Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Pharmaceutical Excipients for Non-injection Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Pharmaceutical Excipients for Non-injection Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Dow
10.1.1 Dow Company Information, Head Office, Market Area, and Industry Position
10.1.2 Dow Pharmaceutical Excipients for Non-injection Models, Specifications, and Application
10.1.3 Dow Pharmaceutical Excipients for Non-injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Dow Company Profile and Main Business
10.1.5 Dow Recent Developments
10.2 Nippon Fine Chemical
10.2.1 Nippon Fine Chemical Company Information, Head Office, Market Area, and Industry Position
10.2.2 Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Models, Specifications, and Application
10.2.3 Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Nippon Fine Chemical Company Profile and Main Business
10.2.5 Nippon Fine Chemical Recent Developments
10.3 Nanjing Well Pharmaceutical
10.3.1 Nanjing Well Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.3.2 Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Models, Specifications, and Application
10.3.3 Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Nanjing Well Pharmaceutical Company Profile and Main Business
10.3.5 Nanjing Well Pharmaceutical Recent Developments
10.4 Jiangsu Maxim Biological
10.4.1 Jiangsu Maxim Biological Company Information, Head Office, Market Area, and Industry Position
10.4.2 Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Models, Specifications, and Application
10.4.3 Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Jiangsu Maxim Biological Company Profile and Main Business
10.4.5 Jiangsu Maxim Biological Recent Developments
10.5 NOF
10.5.1 NOF Company Information, Head Office, Market Area, and Industry Position
10.5.2 NOF Pharmaceutical Excipients for Non-injection Models, Specifications, and Application
10.5.3 NOF Pharmaceutical Excipients for Non-injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 NOF Company Profile and Main Business
10.5.5 NOF Recent Developments
10.6 Croda
10.6.1 Croda Company Information, Head Office, Market Area, and Industry Position
10.6.2 Croda Pharmaceutical Excipients for Non-injection Models, Specifications, and Application
10.6.3 Croda Pharmaceutical Excipients for Non-injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Croda Company Profile and Main Business
10.6.5 Croda Recent Developments
10.7 Jiangsu Poly Pharmaceutical
10.7.1 Jiangsu Poly Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.7.2 Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Models, Specifications, and Application
10.7.3 Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Jiangsu Poly Pharmaceutical Company Profile and Main Business
10.7.5 Jiangsu Poly Pharmaceutical Recent Developments
10.8 Er Kang Pharmaceutical
10.8.1 Er Kang Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.8.2 Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Models, Specifications, and Application
10.8.3 Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Er Kang Pharmaceutical Company Profile and Main Business
10.8.5 Er Kang Pharmaceutical Recent Developments
10.9 Guangzhou Hanfang Pharmaceutical
10.9.1 Guangzhou Hanfang Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.9.2 Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Models, Specifications, and Application
10.9.3 Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Guangzhou Hanfang Pharmaceutical Company Profile and Main Business
10.9.5 Guangzhou Hanfang Pharmaceutical Recent Developments
10.10 Pfanstiehl
10.10.1 Pfanstiehl Company Information, Head Office, Market Area, and Industry Position
10.10.2 Pfanstiehl Pharmaceutical Excipients for Non-injection Models, Specifications, and Application
10.10.3 Pfanstiehl Pharmaceutical Excipients for Non-injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Pfanstiehl Company Profile and Main Business
10.10.5 Pfanstiehl Recent Developments
10.11 Xi'an Libang Pharmaceutical
10.11.1 Xi'an Libang Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.11.2 Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Models, Specifications, and Application
10.11.3 Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Xi'an Libang Pharmaceutical Company Profile and Main Business
10.11.5 Xi'an Libang Pharmaceutical Recent Developments
10.12 Zhejiang Tianyushan Medicinal Oil
10.12.1 Zhejiang Tianyushan Medicinal Oil Company Information, Head Office, Market Area, and Industry Position
10.12.2 Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Models, Specifications, and Application
10.12.3 Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Zhejiang Tianyushan Medicinal Oil Company Profile and Main Business
10.12.5 Zhejiang Tianyushan Medicinal Oil Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Pharmaceutical Excipients for Non-injection Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Pharmaceutical Excipients for Non-injection Market Restraints
Table 3. Pharmaceutical Excipients for Non-injection Market Trends
Table 4. Pharmaceutical Excipients for Non-injection Industry Policy
Table 5. Global Pharmaceutical Excipients for Non-injection Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Pharmaceutical Excipients for Non-injection Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Pharmaceutical Excipients for Non-injection Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Pharmaceutical Excipients for Non-injection Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Pharmaceutical Excipients for Non-injection Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Pharmaceutical Excipients for Non-injection Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Pharmaceutical Excipients for Non-injection Mergers & Acquisitions, Expansion Plans
Table 12. Global Pharmaceutical Excipients for Non-injection Manufacturers Product Type
Table 13. Head Office and Pharmaceutical Excipients for Non-injection Production Site of Key Manufacturer
Table 14. Pharmaceutical Excipients for Non-injection Capacity of Major Manufacturers and Future Plan
Table 15. China Pharmaceutical Excipients for Non-injection Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Pharmaceutical Excipients for Non-injection Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Pharmaceutical Excipients for Non-injection Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Pharmaceutical Excipients for Non-injection Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Pharmaceutical Excipients for Non-injection Production by Region, 2018-2023, (K Units)
Table 20. Global Pharmaceutical Excipients for Non-injection Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Pharmaceutical Excipients for Non-injection Upstream (Raw Materials)
Table 22. Global Pharmaceutical Excipients for Non-injection Typical Customers
Table 23. Pharmaceutical Excipients for Non-injection Typical Distributors
Table 24. By Type, Global Pharmaceutical Excipients for Non-injection Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Pharmaceutical Excipients for Non-injection Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Pharmaceutical Excipients for Non-injection Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Pharmaceutical Excipients for Non-injection Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Pharmaceutical Excipients for Non-injection Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Pharmaceutical Excipients for Non-injection Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Pharmaceutical Excipients for Non-injection Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Pharmaceutical Excipients for Non-injection Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Pharmaceutical Excipients for Non-injection Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Pharmaceutical Excipients for Non-injection Sales Quantity Market Share, 2018-2029
Table 34. Dow Company Information, Head Office, Market Area, and Industry Position
Table 35. Dow Pharmaceutical Excipients for Non-injection Models, Specifications, and Application
Table 36. Dow Pharmaceutical Excipients for Non-injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Dow Company Profile and Main Business
Table 38. Dow Recent Developments
Table 39. Nippon Fine Chemical Company Information, Head Office, Market Area, and Industry Position
Table 40. Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Models, Specifications, and Application
Table 41. Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Nippon Fine Chemical Company Profile and Main Business
Table 43. Nippon Fine Chemical Recent Developments
Table 44. Nanjing Well Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 45. Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Models, Specifications, and Application
Table 46. Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Nanjing Well Pharmaceutical Company Profile and Main Business
Table 48. Nanjing Well Pharmaceutical Recent Developments
Table 49. Jiangsu Maxim Biological Company Information, Head Office, Market Area, and Industry Position
Table 50. Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Models, Specifications, and Application
Table 51. Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Jiangsu Maxim Biological Company Profile and Main Business
Table 53. Jiangsu Maxim Biological Recent Developments
Table 54. NOF Company Information, Head Office, Market Area, and Industry Position
Table 55. NOF Pharmaceutical Excipients for Non-injection Models, Specifications, and Application
Table 56. NOF Pharmaceutical Excipients for Non-injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. NOF Company Profile and Main Business
Table 58. NOF Recent Developments
Table 59. Croda Company Information, Head Office, Market Area, and Industry Position
Table 60. Croda Pharmaceutical Excipients for Non-injection Models, Specifications, and Application
Table 61. Croda Pharmaceutical Excipients for Non-injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Croda Company Profile and Main Business
Table 63. Croda Recent Developments
Table 64. Jiangsu Poly Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 65. Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Models, Specifications, and Application
Table 66. Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Jiangsu Poly Pharmaceutical Company Profile and Main Business
Table 68. Jiangsu Poly Pharmaceutical Recent Developments
Table 69. Er Kang Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 70. Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Models, Specifications, and Application
Table 71. Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Er Kang Pharmaceutical Company Profile and Main Business
Table 73. Er Kang Pharmaceutical Recent Developments
Table 74. Guangzhou Hanfang Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 75. Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Models, Specifications, and Application
Table 76. Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Guangzhou Hanfang Pharmaceutical Company Profile and Main Business
Table 78. Guangzhou Hanfang Pharmaceutical Recent Developments
Table 79. Pfanstiehl Company Information, Head Office, Market Area, and Industry Position
Table 80. Pfanstiehl Pharmaceutical Excipients for Non-injection Models, Specifications, and Application
Table 81. Pfanstiehl Pharmaceutical Excipients for Non-injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Pfanstiehl Company Profile and Main Business
Table 83. Pfanstiehl Recent Developments
Table 84. Xi'an Libang Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 85. Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Models, Specifications, and Application
Table 86. Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Xi'an Libang Pharmaceutical Company Profile and Main Business
Table 88. Xi'an Libang Pharmaceutical Recent Developments
Table 89. Zhejiang Tianyushan Medicinal Oil Company Information, Head Office, Market Area, and Industry Position
Table 90. Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Models, Specifications, and Application
Table 91. Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Zhejiang Tianyushan Medicinal Oil Company Profile and Main Business
Table 93. Zhejiang Tianyushan Medicinal Oil Recent Developments
List of Figures
Figure 1. Pharmaceutical Excipients for Non-injection Picture
Figure 2. Global Pharmaceutical Excipients for Non-injection Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Pharmaceutical Excipients for Non-injection Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Pharmaceutical Excipients for Non-injection Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Pharmaceutical Excipients for Non-injection Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Pharmaceutical Excipients for Non-injection Sales Quantity (K Units) & (2018-2029)
Figure 7. China Pharmaceutical Excipients for Non-injection Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Pharmaceutical Excipients for Non-injection Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Pharmaceutical Excipients for Non-injection Market Share of Global, 2018-2029
Figure 10. Global Pharmaceutical Excipients for Non-injection Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Pharmaceutical Excipients for Non-injection Key Participants, Market Share, 2022
Figure 12. Global Pharmaceutical Excipients for Non-injection Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Pharmaceutical Excipients for Non-injection Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Pharmaceutical Excipients for Non-injection Production Market Share & Forecast by Region, 2018-2029
Figure 15. Pharmaceutical Excipients for Non-injection Industry Chain
Figure 16. Pharmaceutical Excipients for Non-injection Procurement Model
Figure 17. Pharmaceutical Excipients for Non-injection Sales Model
Figure 18. Pharmaceutical Excipients for Non-injection Sales Channels, Direct Sales, and Distribution
Figure 19. Binders
Figure 20. Disintegrants
Figure 21. Lubricants
Figure 22. Fillers
Figure 23. Others
Figure 24. By Type, Global Pharmaceutical Excipients for Non-injection Consumption Value, 2018-2029, US$ Million
Figure 25. By Type, Global Pharmaceutical Excipients for Non-injection Consumption Value Market Share, 2018-2029
Figure 26. By Type, Global Pharmaceutical Excipients for Non-injection Sales Quantity, 2018-2029, (K Units)
Figure 27. By Type, Global Pharmaceutical Excipients for Non-injection Sales Quantity Market Share, 2018-2029
Figure 28. By Type, Global Pharmaceutical Excipients for Non-injection Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 29. Tablets
Figure 30. Capsules
Figure 31. Oral Liquids
Figure 32. Others
Figure 33. By Application, Global Pharmaceutical Excipients for Non-injection Consumption Value, 2018-2029, US$ Million
Figure 34. By Application, Global Pharmaceutical Excipients for Non-injection Consumption Value Market Share, 2018-2029
Figure 35. By Application, Global Pharmaceutical Excipients for Non-injection Sales Quantity, 2018-2029, (K Units)
Figure 36. By Application, Global Pharmaceutical Excipients for Non-injection Sales Quantity Market Share, 2018-2029
Figure 37. By Application, Global Pharmaceutical Excipients for Non-injection Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 38. By Region, Global Pharmaceutical Excipients for Non-injection Consumption Value Market Share, 2018-2029
Figure 39. By Region, Global Pharmaceutical Excipients for Non-injection Sales Quantity Market Share, 2018-2029
Figure 40. North America Pharmaceutical Excipients for Non-injection Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country, North America Pharmaceutical Excipients for Non-injection Consumption Value Market Share, 2022
Figure 42. Europe Pharmaceutical Excipients for Non-injection Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, Europe Pharmaceutical Excipients for Non-injection Consumption Value Market Share, 2022
Figure 44. Asia Pacific Pharmaceutical Excipients for Non-injection Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. By Country/Region, Asia Pacific Pharmaceutical Excipients for Non-injection Consumption Value Market Share, 2022
Figure 46. South America Pharmaceutical Excipients for Non-injection Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 47. By Country, South America Pharmaceutical Excipients for Non-injection Consumption Value Market Share, 2022
Figure 48. Middle East & Africa Pharmaceutical Excipients for Non-injection Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 49. U.S. Pharmaceutical Excipients for Non-injection Sales Quantity, 2018-2029, (K Units)
Figure 50. By Type, U.S. Pharmaceutical Excipients for Non-injection Sales Quantity Market Share, 2022 VS 2029
Figure 51. By Application, U.S. Pharmaceutical Excipients for Non-injection Sales Quantity Market Share, 2022 VS 2029
Figure 52. Europe Pharmaceutical Excipients for Non-injection Sales Quantity, 2018-2029, (K Units)
Figure 53. By Type, Europe Pharmaceutical Excipients for Non-injection Sales Quantity Market Share, 2022 VS 2029
Figure 54. By Application, Europe Pharmaceutical Excipients for Non-injection Sales Quantity Market Share, 2022 VS 2029
Figure 55. China Pharmaceutical Excipients for Non-injection Sales Quantity, 2018-2029, (K Units)
Figure 56. By Type, China Pharmaceutical Excipients for Non-injection Sales Quantity Market Share, 2022 VS 2029
Figure 57. By Application, China Pharmaceutical Excipients for Non-injection Sales Quantity Market Share, 2022 VS 2029
Figure 58. Japan Pharmaceutical Excipients for Non-injection Sales Quantity, 2018-2029, (K Units)
Figure 59. By Type, Japan Pharmaceutical Excipients for Non-injection Sales Quantity Market Share, 2022 VS 2029
Figure 60. By Application, Japan Pharmaceutical Excipients for Non-injection Sales Quantity Market Share, 2022 VS 2029
Figure 61. South Korea Pharmaceutical Excipients for Non-injection Sales Quantity, 2018-2029, (K Units)
Figure 62. By Type, South Korea Pharmaceutical Excipients for Non-injection Sales Quantity Market Share, 2022 VS 2029
Figure 63. By Application, South Korea Pharmaceutical Excipients for Non-injection Sales Quantity Market Share, 2022 VS 2029
Figure 64. Southeast Asia Pharmaceutical Excipients for Non-injection Sales Quantity, 2018-2029, (K Units)
Figure 65. By Type, Southeast Asia Pharmaceutical Excipients for Non-injection Sales Quantity Market Share, 2022 VS 2029
Figure 66. By Application, Southeast Asia Pharmaceutical Excipients for Non-injection Sales Quantity Market Share, 2022 VS 2029
Figure 67. India Pharmaceutical Excipients for Non-injection Sales Quantity, 2018-2029, (K Units)
Figure 68. By Type, India Pharmaceutical Excipients for Non-injection Sales Quantity Market Share, 2022 VS 2029
Figure 69. By Application, India Pharmaceutical Excipients for Non-injection Sales Quantity Market Share, 2022 VS 2029
Figure 70. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales Quantity, 2018-2029, (K Units)
Figure 71. By Type, Middle East & Africa Pharmaceutical Excipients for Non-injection Sales Quantity Market Share, 2022 VS 2029
Figure 72. By Application, Middle East & Africa Pharmaceutical Excipients for Non-injection Sales Quantity Market Share, 2022 VS 2029
Figure 73. Research Methodology
Figure 74. Breakdown of Primary Interviews
Figure 75. Bottom-up and Top-down Approaches
Figure 76. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|